Cargando…

OR05-4 Case Series of Transmasculine Adolescents Who Developed Polycythemia on Gender Affirming Hormone Therapy

STUDY OBJECTIVE: This case series was designed to describe cases of polycythemia among transgender male adolescent patients undergoing treatment with testosterone. METHODS: Retrospective data was collected for our Pediatric Gender Clinic between Jan 2014 and June 2021. Variables assessed included de...

Descripción completa

Detalles Bibliográficos
Autor principal:	Latysheva, Natalya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625165/ http://dx.doi.org/10.1210/jendso/bvac150.1268

Ejemplares similares

OR05-6 Designing a Gender Affirming Hospital: Patient Perspectives on Gender Inclusive Care
por: Fisher, Erin, et al.
Publicado: (2022)

Subcutaneous Testosterone Is Effective and Safe as Gender-Affirming Hormone Therapy in Transmasculine and Gender-Diverse Adolescents and Young Adults: A Single Center's 8-Year Experience
por: Laurenzano, Sarah E., et al.
Publicado: (2021)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

Barriers to Gender-affirming Surgery Consultations in a Sample of Transmasculine Patients in Boston, Mass.
por: Tabaac, Ariella R., et al.
Publicado: (2020)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

ODP148 GENDER AFFIRMING HORMONE THERAPY AND SPONTANEOUS CORONARY ARTERY DISSECTION
por: Yogeswaran, Vidhushei, et al.
Publicado: (2022)

Gender-Affirming Hormone Therapy: Physical and Sociopsychological Effects, Impact and Satisfaction
por: Santos, Rafael B, et al.
Publicado: (2023)

PMON192 Impact of Gender-Affirming Care Learning Module on Medical Students’ Knowledge and Self-Efficacy
por: Mokatrin, M×Raneem, et al.
Publicado: (2022)

PSAT116 Perceived Facilitators and Barriers Using Telemedicine for Gender-Affirming Care in Youth: A Qualitative Study
por: Inwards-Breland, David, et al.
Publicado: (2022)

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

Health and Access to Gender-Affirming Care During COVID-19: Experiences of transmasculine individuals and men assigned female sex at birth
por: D’Angelo, Alexa B., et al.
Publicado: (2021)

Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care?
por: Xu, Jane Y., et al.
Publicado: (2021)

SUN-LB14 Trans and Non-Binary Youth Accessing Gender Affirming Medical Care in Canada: New Research From the Trans Youth CAN!
por: Mokashi, Arati, et al.
Publicado: (2020)

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2020)

Pelvic pain in transmasculine adolescents receiving testosterone therapy
por: Moussaoui, Dehlia, et al.
Publicado: (2022)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

OR05-5 Body Mass Index (BMI) as a Predictor of Bone Mineral Density (BMD) in Gender Diverse Youth
por: Rodriguez Gonzalez, Adriana, et al.
Publicado: (2022)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

OR31-05 Long-Term Effects Of Gender Affirming Hormone Therapy On Insulin Sensitivity, Insulin Secretion, And Glucose Tolerance
por: Pinkson, Sheila, et al.
Publicado: (2023)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

ODP415 Inclusion Health Clinic: Gender-Affirming Hormone Therapy & Surgery Booklet and Review of Efficacy in Patient-Provider Encounters
por: Pulsiano, Sune Wolf, et al.
Publicado: (2022)

Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents
por: Carswell, Jeremi M., et al.
Publicado: (2017)

Long-Term Growth Hormone Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)

Endometriosis in transmasculine individuals
por: Ferrando, Cecile A
Publicado: (2022)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

100. Patterns of Perioperative Hormone Therapy for Gender-affirming Surgery
por: Hung, Ya-Ching, et al.
Publicado: (2023)

THU189 Complex Treatment Of Recurrent Gynecomastia In An Affirmed Male With 46XX Ovotesticular Difference Of Sexual Differentiation (DSD).
por: Jumani, Sanjay, et al.
Publicado: (2023)

ODP389 Lipid Peroxidation System Reactivity in Adolescents During Constitutional Obesity Non-drug Therapy
por: Darenskaya, Marina, et al.
Publicado: (2022)

SAT-291 Gonadotropin Releasing Hormone Agonist Therapy Improves Hyperandrogenism in an Adolescent with Type A Insulin Resistance Syndrome
por: Paprocki, Emily, et al.
Publicado: (2019)

ODP619 Trends in Obesity in Gender Diverse Adolescents in Northern Nevada
por: Miah, Faria, et al.
Publicado: (2022)

Transgender and Gender-nonbinary Patient Satisfaction after Transmasculine Chest Surgery
por: Bustos, Valeria P., et al.
Publicado: (2021)

Temporal Trends in Gender Affirmation Surgery Among Transgender and Non-Binary Minors
por: Hassan, Bashar, et al.
Publicado: (2023)

Diagnosis of Childhood and Adolescent Growth Hormone Deficiency Using Transcriptomic Data
por: Garner, Terence, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qec3ue6kd54tq0vich40ec0di2